Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.

Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.

Thorax. 2005 Jun;60(6):480-7.

PMID:
15923248
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Nannini LJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD006829. doi: 10.1002/14651858.CD006829.pub2. Review.

PMID:
22972099
[PubMed - indexed for MEDLINE]
3.

Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease.

Fenton C, Keating GM.

Drugs. 2004;64(17):1975-96. Review.

PMID:
15329047
[PubMed - indexed for MEDLINE]
4.

Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease.

Lyseng-Williamson KA, Keating GM.

Am J Respir Med. 2002;1(4):273-82; discussion 283-4. Review.

PMID:
14720047
[PubMed - indexed for MEDLINE]
5.

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.

Masoli M, Weatherall M, Holt S, Beasley R.

Thorax. 2005 Sep;60(9):730-4. Review.

PMID:
16135679
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Welsh EJ, Cates CJ, Poole P.

Cochrane Database Syst Rev. 2010 May 12;(5):CD007891. doi: 10.1002/14651858.CD007891.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD007891.

PMID:
20464758
[PubMed - indexed for MEDLINE]
7.

The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.

Hanania NA.

Pulm Pharmacol Ther. 2008;21(3):540-50. doi: 10.1016/j.pupt.2007.12.004. Epub 2008 Jan 6. Review.

PMID:
18280761
[PubMed - indexed for MEDLINE]
8.

Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease.

Keating GM, McCormack PL.

Drugs. 2007;67(16):2383-405. Review.

PMID:
17983257
[PubMed - indexed for MEDLINE]
9.
10.

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

Chung KF, Caramori G, Adcock IM.

Eur J Clin Pharmacol. 2009 Sep;65(9):853-71. doi: 10.1007/s00228-009-0682-z. Epub 2009 Jun 26. Review.

PMID:
19557399
[PubMed - indexed for MEDLINE]
11.

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.

Yawn BP, Raphiou I, Hurley JS, Dalal AA.

Int J Chron Obstruct Pulmon Dis. 2010 Jun 3;5:165-78. Review.

PMID:
20631816
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Should inhaled corticosteroids be used in the long term treatment of chronic obstructive pulmonary disease?

Burge S.

Drugs. 2001;61(11):1535-44. Review.

PMID:
11577791
[PubMed - indexed for MEDLINE]
13.

Salmeterol/fluticasone combination in the treatment of COPD.

Chung KF.

Int J Chron Obstruct Pulmon Dis. 2006;1(3):235-42. Review.

PMID:
18046860
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.

Dransfield MT, Bailey WC.

Expert Opin Pharmacother. 2004 Aug;5(8):1815-26. Review.

PMID:
15264996
[PubMed - indexed for MEDLINE]
15.

Seretide for obstructive lung disease.

Chapman KR.

Expert Opin Pharmacother. 2002 Mar;3(3):341-50. Review.

PMID:
11866683
[PubMed - indexed for MEDLINE]
16.

Are Seretide and Symbicort useful in COPD?

[No authors listed]

Drug Ther Bull. 2004 Mar;42(3):18-21. Review.

PMID:
15038079
[PubMed - indexed for MEDLINE]
17.

The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.

Cave AC, Hurst MM.

Pharmacol Ther. 2011 May;130(2):114-43. doi: 10.1016/j.pharmthera.2010.12.008. Epub 2011 Jan 27. Review.

PMID:
21276815
[PubMed - indexed for MEDLINE]
18.

Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.

Sin DD, Man SF.

Drugs Aging. 2003;20(12):867-80. Review.

PMID:
14565780
[PubMed - indexed for MEDLINE]
19.

[Evidence of pharmacotherapy in COPD--key findings from recently-conducted randomized clinical studies].

Shimizu K, Nishimura M.

Nihon Rinsho. 2011 Oct;69(10):1815-20. Review. Japanese.

PMID:
22073579
[PubMed - indexed for MEDLINE]
20.

[Inhaled corticosteroids for COPD].

Dekhuijzen PN.

Ned Tijdschr Geneeskd. 2003 Jul 19;147(29):1398-404. Review. Dutch.

PMID:
12894463
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk